Q.01

What is an NHS serious shortage protocol?

A serious shortage protocol (SSP) is a written protocol issued by UK Health Ministers when they think the UK, or part of it, is having or may have a serious shortage of a prescription-only medicine. While it is in force, a pharmacist can supply something other than what the prescription says without going back to the prescriber. The legal basis is regulation 226A of the Human Medicines Regulations 2012, inserted on 9 February 2019 by S.I. 2019/62 [1].

What the law says (regulation 226A) [1]

  • What it does: Normally a pharmacy must dispense exactly what is prescribed (regulation 214(1)). That rule "does not apply" to a retail pharmacy business supplying a prescription-only medicine if three conditions are met:
    • A: the medicine is supplied in accordance with an SSP.
    • B: the SSP's requirements on who may receive it, and on what conditions, are satisfied.
    • C: a pharmacist, using professional skill and judgement, considers the substitution reasonable and appropriate. The supply must be made by the pharmacist or under their supervision.
  • What an SSP can allow (paragraph 5(b)):
    • a different strength, quantity or pharmaceutical form of the prescribed medicine; or
    • a different prescription-only medicine.
  • Limits on substitute medicines (paragraph 5(c)): a different medicine must be one of these:
    • a generic version;
    • for a biological medicine, a similar (biosimilar) product; or
    • a medicine with a similar therapeutic effect.
  • Mandatory content (paragraph 5(d)): each SSP must state how long it lasts and which parts of the UK it covers.
  • Review: Ministers "must" review how the scheme worked after its first year, report on it and publish the report (paragraph 6).

How SSPs work in practice (NHSBSA register)

  • Who issues and runs them: Each SSP has a reference number, is signed off by a minister, and is issued by the Secretary of State for Health and Social Care. NHS Prescription Services handles queries [2].
  • Pharmacist duties: Supplying under an SSP is the registered pharmacist's decision, and they "must abide by the protocol". Pharmacists must use an SSP only within its authorised dates and criteria. Changing the document makes the SSP invalid [2].
  • Telling the GP: When a therapeutic equivalent is supplied, the pharmacist will need to inform the patient's GP practice, generally within the next working day. For a change of quantity, form or strength, or a generic, the prescriber may not always need to be told [2].
  • Patient consent: If the patient or carer does not consent, they fall outside the SSP [2].
  • Prescription charges: No NHS prescription charge applies when an SSP only cuts the quantity supplied [2].

Examples

  • Switching strength or form (early SSPs):
    • SSP003 (October 2019, England only) let pharmacists give 2 x 20 mg fluoxetine capsules instead of 40 mg capsules. It was used 2,844 times [3].
    • SSP004 (England and Wales) let them give a haloperidol 500 microgram tablet instead of capsules [4].
  • Switching brand: SSP012 allowed Evorel or Estraderm MX patches in place of Estradot 75 microgram patches [5].
  • Limiting quantity (recent SSPs):
    • SSP088 and SSP089, valid 9 September 2026 to 15 January 2027 and UK-wide, limit lansoprazole 15 mg and 30 mg orodispersible tablets to one month's supply per prescription. They cover NHS and private prescriptions [6][2].
    • SSP087 did the same for ramipril 1.25 mg capsules; its register validity ran 22 April to 30 October 2026 [7].

Approach: I read regulation 226A in the current revised Human Medicines Regulations 2012 and the NHSBSA register of SSPs, including the signed protocol forms. I also checked the list of first-year SSPs in the Department of Health and Social Care's one-year policy review (May 2021).

Q.02

How do pharmacists check whether they can use one?

A pharmacist first checks the NHSBSA register to confirm a current SSP covers the prescribed medicine and that today falls within its dates. Then, for each prescription, they work through the signed protocol: inclusion and exclusion criteria, patient consent, their own professional judgement, and any duty to tell the GP. The protocol puts the duty on the pharmacist: they "must ensure that it is only used within its authorised dates and within the criteria set out within the SSP" and "must check that they are using the current version" [2].

Step 1: Is there a valid SSP for this medicine, here, today?

  • Find it on the register. The protocol directs pharmacists to the NHSBSA SSP page for current versions. Amendments "may become necessary prior to the published expiry date", so a printed copy may be out of date [2].
  • Match the exact product. Each SSP names one medicine, strength and form. A prescription for anything else is excluded [2].
  • Check the dates and the latest version. The register can show a later end date than the signed form you hold:
    • SSP080 (Estradot 75 microgram): the version 1.0 form shows an expiry of 19/1/2025. The register now gives 19 December 2024 to 8 January 2027, amended 2 October 2026 [8].
    • SSP087 (ramipril 1.25 mg): the register still labels it "active", but its stated validity ended on 30 October 2026, so it is outside its dates today [7].
  • Check where it applies and to which prescriptions. Each form states the UK nations it covers and its scope. SSP089 and SSP080 are both UK-wide and cover all NHS and private prescriptions [2][8].

SSPs within their register dates today (7 November 2026)

SSPMedicineRegister validity
SSP088Lansoprazole 15 mg orodispersible tablets9 Sep 2026 to 15 Jan 2027 [6]
SSP089Lansoprazole 30 mg orodispersible tablets9 Sep 2026 to 15 Jan 2027 [2]
SSP079Estradot 50 microgram patches19 Dec 2024 to 8 Jan 2027, amended 2 Oct 2026 [9]
SSP080Estradot 75 microgram patches19 Dec 2024 to 8 Jan 2027, amended 2 Oct 2026 [8]
SSP081Estradot 100 microgram patches19 Dec 2024 to 8 Jan 2027, amended 2 Oct 2026 [10]
SSP082Estradot 25 microgram patches3 Apr 2025 to 8 Jan 2027, amended 2 Oct 2026 [11]
SSP061Creon 25000 capsules24 May 2024 to 8 Jan 2027, amended 2 Oct 2026 [12]

Step 2: Does this patient qualify?

  • Inclusion criteria: The patient must have a valid prescription that meets the Human Medicines Regulations 2012. Some SSPs add conditions:
    • SSP089 only applies where the prescription is for more than one month's supply [2].
    • SSP080 only covers patients aged 18 or over [8].
  • Exclusion criteria: These include:
    • a different medicine or an invalid prescription;
    • no consent from the patient or carer;
    • for SSP080, known hypersensitivity or severe adverse reaction to the substitute patches, or the pharmacist judging the patient unsuitable [8].
  • If the patient is excluded or declines: The form says what to do.
    • Under SSP080 the patient "should be referred back to their prescriber promptly" [8].
    • Under SSP089 a prescription for one month or less is dispensed in full if stock is available. Otherwise the patient is referred to another pharmacy or back to the prescriber [2].

Step 3: Supply exactly as the protocol says, then do the follow-up

  • Decision and supervision: The decision to supply rests with the registered pharmacist, who "must abide by the protocol". Other pharmacy staff may help, but under the pharmacist's supervision. Altering the document invalidates the SSP [2].
  • Quantities and substitutes are fixed: For example, SSP080 allows 1 Evorel or 1 Estraderm MX 75 microgram patch for each Estradot patch. It does not allow less than the number of days prescribed [8].
  • Counselling: SSP089 requires telling patients to reorder from their prescriber on time [2]. SSP080 requires counselling on side effects such as breakthrough bleeding and patch irritation or adhesion [8].
  • Telling the prescriber:
    • When a therapeutic equivalent is supplied, the GP practice must be informed, generally by the next working day, using NHSmail unless a local channel is preferred [8].
    • In Northern Ireland, the SSP080 addendum says details should go to the prescriber "within 3 working days" [8].
    • For quantity, form or strength changes, or a generic, the prescriber may not need telling unless the SSP or national arrangements say so [2].
  • Questions: Queries about an SSP's content go to NHS Prescription Services (0300 330 1349, nhsbsa.prescriptionservices@nhsbsa.nhs.uk) [2].

Approach: I read the NHSBSA serious shortage protocol register, including the signed protocol forms for SSP089 (a quantity limit) and SSP080 (a brand switch). I did not open separate NHSBSA endorsement or claiming guidance.

Q.03